Newswise — [CHICAGO, IL, October 25, 2022] — As the American Neurological Association’s 147th Annual Meeting wraps up today, October 25, the ANA is holding a Media Roundtable at 11 a.m. U.S. Central for reporters to access the latest developments in neurology and neuroscience. The Media Roundtable is your opportunity to connect with leading neurologists about key developments in their fields.
The ANA2022 meeting is the key venue for academic neurology and neuroscience research, attracting clinicians, academics and researchers across specialties. This year’s scientific sessions focus on groundbreaking topics – such as the connections between environmental pollutants and the rise in Parkinson’s disease – and are already receiving high-level media attention.
The Media Roundtable will feature the following speakers discussing these developing areas:
- Frances E. Jensen, MD, FACP, FANA (University of Pennsylvania), Neurologic Dark Matter: Exploring the Exposome that Drives Neurological Disorders: The ANA2022 Presidential Symposium focused on alarming connections emerging between neurologic disease and exposures to environmental chemicals and pollution. View press release.
- Roy H. Hamilton, MD, MS, FANA (University of Pennsylvania), Advancing Neurologic Equity: Challenges and Paths Forward: Causes and consequences of neurologic disparities, and approaches to advance more equitable, inclusive neuroscience and neurologic care.
- Krishnankutty Sathian, MBBS, PhD, FANA (Pennsylvania State University), Novel Perspectives on Neurodegeneration: New insights from studies of neurodegenerative diseases that focus on underlying mechanisms and genetic diversity.
- Jack M. Parent, MD, FANA (University of Michigan), Brain Organoid Models of Neurological Disorders: A novel approach to study brain disorders using 3D human tissue structures.
- Sattar Khoshkhoo, MD (Brigham and Women’s Hospital)* and Annapurna Poduri, MD, MPH (Boston Children’s Hospital)*, Emerging Role of Somatic Mutations in Neurology: New treatment pathways for disorders like epilepsy are coming into view, partly thanks to research in somatic mutations: post-zygotic genetic changes that result in genetic variants present in only part of the body or brain.
- Sheng-Han Kuo, MD (Columbia University), Peripheral Contributions to Neurologic Disorders: Adaptive Immunity and Metabolic Influences: Emerging research highlighting the role of non-neurological systems—from the gut microbiome and insulin to the immune system—in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
*Not present at roundtable; will provide pre-written highlights
The roundtable will feature the session chairs above discussing highlights of each plenary session, with opportunity for members of the media to ask questions.
View the ANA Newsroom for more research highlights from the ongoing American Neurological Association 147th Annual Meeting in Chicago. View the Press Kit for full meeting abstracts and more information.
The 147th ANA Annual Meeting takes place October 22–25, 2022 at the Hyatt Regency in Chicago, IL. The organization’s first in-person annual meeting since the beginning of the COVID-19 pandemic, ANA2022 will bring together close to 1,000 top academic neurologists and neuroscientists, along with students and trainees, from across the United States and internationally.
The meeting will showcase emerging science across neurology, including a Presidential Symposium on the effect of environmental contamination on the brain (“Neurologic Dark Matter: Exploring the Exposome that Drives Neurological Disorders”) and plenary sessions including Novel Perspectives on Neurodegeneration, Brain Organoid Models of Neurological Disorders, Emerging Role of Somatic Mutations in Neurology, Advancing Neurologic Equity, and Peripheral Contributions to Neurologic Disorders.
About the American Neurological Association (ANA)
From advances in stroke and dementia to movement disorders and epilepsy, the American Neurological Association has been the vanguard of research since 1875 as the premier professional society of academic neurologists and neuroscientists devoted to understanding and treating diseases of the nervous system. Its monthly Annals of Neurology is among the world’s most prestigious medical journals, and the ANA’s Annals of Clinical and Translational Neurology is an online-only, open access journal providing rapid dissemination of high-quality, peer-reviewed research related to all areas of neurology. The acclaimed ANA Annual Meeting draws faculty and trainees from the top academic departments across the U.S. and abroad for groundbreaking research, networking, and career development. For more information, visit www.myana.org or @TheNewANA1.